Literature DB >> 29959055

The multifaceted role of glutathione S-transferases in cancer.

Anupam Chatterjee1, Sanjay Gupta2.   

Abstract

Glutathione S-transferases (GSTs) are phase II detoxifying enzymes involved in the maintenance of cell integrity, oxidative stress and protection against DNA damage by catalyzing the conjugation of glutathione to a wide variety of electrophilic substrates. Though enzymes of the glutathione synthesis and salvage pathways have been well characterized in the past, there is still a lack of comprehensive understanding of their independent and coordinate regulatory mechanisms in carcinogenesis. The present review discusses implication of GST in cancer development and progression, gene polymorphism, drug resistance, signaling and epigenetic regulation involving their role in cancer. It is anticipated that GST especially the GSTP1 class can be developed as a biomarker either used alone or in combination with other biomarkers for early cancer detection and/or diagnosis as well as for future targeted preventive and therapeutic interventions with dietary agents.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Biomarkers; Carcinogenesis; Drug resistance; Glutathione-S transferase; Tumor suppressor

Mesh:

Substances:

Year:  2018        PMID: 29959055     DOI: 10.1016/j.canlet.2018.06.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  37 in total

1.  Beyond drugs: the evolution of genes involved in human response to medications.

Authors:  Silvia Fuselli
Journal:  Proc Biol Sci       Date:  2019-10-23       Impact factor: 5.349

2.  Centrosome Loss Triggers a Transcriptional Program To Counter Apoptosis-Induced Oxidative Stress.

Authors:  John S Poulton; Daniel J McKay; Mark Peifer
Journal:  Genetics       Date:  2019-03-13       Impact factor: 4.562

Review 3.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

4.  GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients.

Authors:  Juanzi Zeng; Heming Wu; Donghua Liu; Liang Li; Jiaquan Li; Qiuming Wang; Min Ye; Qingyan Huang; Zhikang Yu; Jinfeng Zhang
Journal:  World J Surg Oncol       Date:  2022-06-22       Impact factor: 3.253

Review 5.  Glutathione S-Transferases in Cancer.

Authors:  Rahul Raj Singh; Katie M Reindl
Journal:  Antioxidants (Basel)       Date:  2021-04-29

Review 6.  The role of ROS in tumour development and progression.

Authors:  Eric C Cheung; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2022-01-31       Impact factor: 60.716

7.  Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging Molecules.

Authors:  Xiaona Li; Zirui Lü; Cong Wang; Kebin Li; Fengrong Xu; Ping Xu; Yan Niu
Journal:  ACS Med Chem Lett       Date:  2021-05-03       Impact factor: 4.345

8.  Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.

Authors:  Zehua Zhang; Qiang Zhou; Fei Luo; Rui Zhou; Jianzhong Xu; Jun Xiao; Fei Dai; Lei Song
Journal:  Hum Cell       Date:  2021-06-23       Impact factor: 4.174

Review 9.  GSTP1 as a novel target in radiation induced lung injury.

Authors:  Xiao Lei; Lehui Du; Wei Yu; Yao Wang; Na Ma; Baolin Qu
Journal:  J Transl Med       Date:  2021-07-08       Impact factor: 5.531

10.  HSD17B7 gene in self-renewal and oncogenicity of keratinocytes from Black versus White populations.

Authors:  Xiaoying Xu; Beatrice Tassone; Paola Ostano; Atul Katarkar; Tatiana Proust; Jean-Marc Joseph; Chiara Riganti; Giovanna Chiorino; Zoltan Kutalik; Karine Lefort; Gian Paolo Dotto
Journal:  EMBO Mol Med       Date:  2021-06-29       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.